LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 821 pages found matching toyota recalls- Surgical Stapler Lawsuit Information and Legal News
Surgical stapler lawsuits aimed at medical device manufacturers claim that these defective surgical staplers have caused serious injuries—for many years: The majority of complications were concealed from the public by the FDA in a “hidden database” and have just recently been made public. Defective Surgical Staplers Surgical stap... - Medtronic Insulin Pump Lawsuit News and Legal Information
Medtronic has so far faced at least two lawsuits alleging the Medtronic MiniMed Paradigm insulin pumps are defective and have caused the death of patients relying on the pumps to monitor blood glucose levels. There have been at least two Medtronic recalls of the devices, linked to problems with the pumps providing too much or too little insulin. Attor... - Alere INRatio Recall Legal News and Lawsuit Information
The Alere INRatio Monitoring System is a handheld device used by patients to monitor amounts of the blood-thinning drug Warfarin . While these drugs prevent blood clots , too little or too much can be life-threatening—accurate monitoring is crucial, especially if the patient is self-monitoring their blood levels at home. The INRatio2 system was... - Massive Auto Recalls Issued by Tranport Canada
Cars, Trucks, Motorcycles all Involved Transport Canada has issued a recall notice which affects vehicles made by Toyota, Lexus, Ford, Chevrolet, BMW, Dodge, Maserati, Mazda and Bentley, and motorcycles made by BMW, Suzuki and Kawasaki. TOYOTA SIENNA: Vehicles affected: 26,501 On certain vehicles, if the retention clip used to secure the center... - FDA Pulls Zantac off Shelves
Jul-6-20 Washington, DC On April 1, the federal Food and Drug Administration asked manufacturers to withdraw Zantac and all other prescription and over-the-counter ranitidine drugs from the market immediately. It has also advised those who use OTC ranitidine medications to stop taking them immediately and patients with ranitidine prescriptions to speak with their... - Zantac Associated with Breast Cancer
May-20-20 Santa Clara, CA Several Zantac breast cancer lawsuits have been filed against the drug manufacturers, 12 years after a peer-reviewed study from the Fred Hutchinson Cancer Research Center linked Zantac with breast cancer. The Zantac Breast Cancer Study The study , authored by the American Association for Cancer Research and American Society of Prev... - FDA Finally Pulls Zantac
Apr-17-20 Washington, DC Since at least last summer the FDA has known that a contaminant known as N-Nitrosodimethylamine (NDMA) was present in ranitidine medications (commonly known as the brand name Zantac ), but the agency didn’t order a withdrawal of the popular heartburn drug until this month – almost a year later. Chances are, countless people who... - Zantac Cancer Lawsuits Move to MDL Phase
Mar-20-20 West Palm Beach, FL Zantac cancer lawsuits will be consolidated in multidistrict litigation in the U.S. District Court for the Southern District of Florida. At the time of its formation on February 6, the MDL included 15 cases. An additional 126 cases were pending in 21 districts nationwide, and more plaintiffs are expected to join. The consolidated la... - Rantidine Recalls Stoke Zantac Cancer Lawsuits
Feb-12-20 Washington, DC A cascade of recalls – by Sanofi, the manufacturer of Zantac and a collection of pharmacies that distribute the heartburn drug – is fuel to the fire of the Zantac cancer lawsuits now forming. Lawyers reportedly anticipate an explosion of Zantac lawsuits over the next several months. What should heartburn sufferers who have... - General Motors Faulty Ignition Lawsuit News & Legal Informatio
General Motors in 2014 recalled 2.6 million vehicles involving GM ignition switches that could potentially turn off on their own, shutting down the engine and disabling airbags while the vehicle was in motion. The faulty ignition switches were used in various models, mainly the Chevrolet Cobalt and Saturn Ion, which GM started manufacturing in 2002 and 2003... - New Research: Brief Heat Exposure Increases Zantac Cancer Odds
Jan-14-20 Washington, DC Emery Pharma, a California-based testing laboratory has reported that Zantac appears to produce unacceptably high levels of cancer-causing N-Nitrosodimethylamine (NDMA) when exposed to heat for as little as five days. Brief periods of modestly inadequate temperature control can easily occur during transport, storage or even in consumer&rsq... - More Ranitidine Cancer Concerns Lead to Zantac Lawsuits
Jan-9-20 Santa Clara, CA Since the FDA last September reported that minute amounts of a carcinogen called N-nitrosodimethylamine (NDMA) was detected in Zantac, along with several other heartburn medications, a number of Zantac cancer lawsuits have followed. The FDA and Zantac Despite voluntary recalls from manufacturers (including Sanofi and Glenmark... - Unconscionable Arbitration Agreements; Less than Candid Lawyers
Nov-26-19 San Francisco, CA On October 30 a California state appellate court denied an effort by TWC Dealer Group to compel former employees to arbitrate violations of California labor law including race and age discrimination, wage violations and wrongful termination. The takeaway for workers forced to arbitrate is a lesson in what constitutes an unconsci... - More Zantac Cancer Lawsuits and Recalls
Nov-19-19 Santa Clara, CA As more pharmaceutical companies are hit with Zantac cancer lawsuits , they are recalling the acid reflux medication in the U.S. and Canada over complaints of a link to a probable carcinogen called called N-nitrosodimethylamine (NDMA), a chemical that has already been found in animals. What a difference one month can make. The FDA on Oc... - Zantac Medication Cancer Legal News & Lawsuit Information
Zantac (ranitidine hydrochloride) is being investigated after 150 Zantac tablets were found to contain a carcinogenic chemical up to 3,000 times greater than the FDA’s daily intake limit. The chemical found in the popular heartburn drug is N-nitrosodimethylamine (“NDMA”). Numerous studies have shown a link between the NDMA in Zantac and can... - Does Bayer Regret Buying Monsanto?
Oct-18-19 St Louis, MO: About 18,400 Monsanto glyphosate lawsuits alleging Roundup cancer are bound to put a large dent into the $63 billion that Bayer bought St. Louis-based Monsanto for last year. While Bayer knew it inherited the Roundup lawsuits, one plaintiff attorney believes the German pharmaceutical company wasn’t anticipating the high cost of losing. ... - Taylor Farm’s Don-Doff Deal is Off
Sep-18-19 Tracy, CA A proposed $5.3 million settlement by Taylor Farms Pacific Inc. to resolve claims that employees were not paid for donning and doffing and other California labor law violations was declined by a California federal judge last month, because the court “cannot simply rubber stamp a class action settlement.” Along with the donning and... - ZF-TRW Holdings and Six Automakers Slammed with Defective Airbag Class Action Lawsuits
Jul-22-19 Santa Clara, CA: German airbag manufacturer ZF TRW Automotive Holdings Corp. and six major automakers have been slammed with class action defective airbag lawsuits alleging ZF TRW airbags are defective. The defective airbags have been linked to at least eight deaths and several serious injuries. The class action lawsuits were filed on the heels of a N... - Valsartan Recall Lawsuits Filed over Alleged Carcinogenic Contaminants
Sep-17-18 Washington, DC On August 27, 2018, the Food and Drug Administration published updated press information that expands its original July 17 valsartan recall notice. Sixteen companies have now announced voluntary recalls of blood pressure and heart medications. Valsartan is an off-patent component of several commonly prescribed drugs used to treat hig... - Valsartan Cancer Risk Legal News and Lawsuit Information
The drug Valsartan (a generic version of Diovan), which is prescribed to treat high blood pressure and prevent heart failure, has been recalled worldwide after it was found to contain N-nitrosodimethylamine (NDMA), a known carcinogen. Valsartan contamination from a Chinese manufacturing plant may date back to 2012, potentially exposing many patients to Valsa...